Gsk (GSK) Shares Issued (2009 - 2026)
Gsk (GSK) recorded quarterly Shares Issued of $10.8 million in Q1 2026, up 710.83% quarter-over-quarter from $1.3 million in Q4 2025, and down 28.64% on a YoY basis from $15.1 million in Q1 2025.
Gsk (GSK) Shares Issued (2009 - 2026) Analysis & Trends
Gsk's Shares Issued history runs 18 years deep, the most recent figure standing at $10.8 million for Q1 2026.
- In Q1 2026, Shares Issued fell 28.64% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $51.6 million (down 29.78% YoY), while the FY2025 annual figure was $19.8 million, down 22.64% from the prior year.
- Shares Issued was $10.8 million for Q1 2026 at Gsk, up from $1.3 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $24.4 million in Q4 2024 to a low of $1.3 million in Q4 2025.
- Historically, Shares Issued has averaged $15.7 million across 5 years, with a median of $15.1 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Shares Issued jumped 134.81% in 2024, then tumbled 94.55% in 2025.
- A 5-year view of Shares Issued shows it stood at $23.5 million in 2022, then slumped by 52.38% to $11.2 million in 2023, then jumped by 118.31% to $24.4 million in 2024, then sank by 94.55% to $1.3 million in 2025, then surged by 710.83% to $10.8 million in 2026.
- The last three Shares Issued figures came in at $10.8 million (Q1 2026), $1.3 million (Q4 2025), and $15.1 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.79 Mn |
| Mar 31, 2026 | 10.79 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 15.11 Mn |
| Mar 31, 2025 | 15.11 Mn |
| Dec 31, 2024 | 24.39 Mn |
| Dec 31, 2024 | 24.39 Mn |
| Mar 31, 2024 | 22.83 Mn |
| Mar 31, 2024 | 22.83 Mn |
| Dec 31, 2023 | 11.17 Mn |
| Dec 31, 2023 | 11.17 Mn |
| Mar 31, 2023 | 9.72 Mn |
| Mar 31, 2023 | 9.72 Mn |
| Dec 31, 2022 | 23.46 Mn |
| Dec 31, 2022 | 23.46 Mn |
| Mar 31, 2022 | 22.81 Mn |
| Mar 31, 2022 | 22.81 Mn |
| Dec 31, 2021 | 25.61 Mn |
| Dec 31, 2021 | 25.61 Mn |